Generate a tailored SOP for Dr. John Maher. Improve your application with a focused, well-structured draft.
John Maher is a Senior Lecturer in the Comprehensive Cancer Centre at King's College London, specializing in Cancer Immunology. He focuses on developing innovative immunotherapeutic strategies, particularly CAR-T cell therapies, targeting various malignancies. His research emphasizes the potential of immune cells in treating cancers such as pancreatic and head and neck carcinoma. He has been actively involved in research to harness the tumor-intrinsic interferon signaling pathways to combat cancer resistance. He leads projects exploring the engineering of T cells with enhanced specificity and efficacy for tumor targeting, as well as advancements in CAR-T technologies. His group, CAR Mechanics, has been pivotal in translating laboratory research into clinical trials and has received significant funding from various institutions, including the Wellcome Trust and Jon Moulton Charitable Foundation. Dr. Maher is dedicated to advancing the understanding of host-tumor interactions and therapeutic targets, aiming to stimulate collaborations across research fields to innovate treatments that better respond to cancer therapies.
Requirements are consistent across King's Business School and Social Science & Public Policy departments for standard Master's entries.